SELLAS Life Sciences Group (SLS) Institutional Ownership $1.70 -0.24 (-12.37%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.71 +0.01 (+0.82%) As of 08:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$10.03MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$49.34K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Anson Funds Management LP7,579,095$8.19M1.2%+535.7%8.016% 5/12/2025 Virtu Financial LLC53,861$58K0.0%+30.9%0.057% 2/28/2025 Brooklyn FI LLC594,919$677K0.1%N/A0.845% 2/17/2025 Anson Funds Management LP1,192,266$1.24M0.1%+50.2%1.694% 2/14/2025 Northern Trust Corp134,721$140K0.0%+33.6%0.191% 2/13/2025 XTX Topco Ltd53,426$56K0.0%-14.9%0.076% 2/12/2025 Geode Capital Management LLC733,546$763K0.0%+21.2%1.042% 2/11/2025 Virtu Financial LLC41,155$43K0.0%-48.1%0.058% 2/11/2025 Brooklyn FI LLC594,919$677K0.0%N/A0.845% 1/31/2025 Opus Capital Group LLC238,500$248K0.0%+5.5%0.339% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 11/20/2024 Virtu Financial LLC79,241$99K0.0%+24.1%0.113% 11/16/2024 Geode Capital Management LLC605,191$757K0.0%+17.1%0.941% 11/15/2024 Anson Funds Management LP793,835$992K0.0%N/A1.234% 11/15/2024 XTX Topco Ltd62,785$78K0.0%N/A0.098% 11/15/2024 State Street Corp174,529$218K0.0%+30.2%0.271% 8/9/2024 Renaissance Technologies LLC32,446$39K0.0%N/A0.056% 5/20/2024 Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024 Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024 Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024 Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024 Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023 Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023 Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023 Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022 GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022 Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021 Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021 Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021 Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021 Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021 Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021 State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021 Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021 Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021 Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021 Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is8/12/2021 Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021 Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 11 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Anson Funds Management LP ($8.19M), Armistice Capital LLC ($869K), Geode Capital Management LLC ($763K), Brooklyn FI LLC ($677K), Opus Capital Group LLC ($248K), State Street Corp ($218K), and Northern Trust Corp ($140K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? Of the 11 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($12.41M), Brooklyn FI LLC ($1.19M), Armistice Capital LLC ($820K), Geode Capital Management LLC ($216.54K), Opus Capital Group LLC ($178.50K), XTX Topco Ltd ($62.79K), and State Street Corp ($40.50K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 15,043,852 shares in the last 24 months. This purchase volume represents approximately $16.00M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Virtu Financial LLC ($58.57K), and XTX Topco Ltd ($9.36K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 67,930 shares in the last 24 months. This volume of shares sold represents approximately $70.03K in transactions. Related Companies Sionna Therapeutics Major Shareholders Keros Therapeutics Major Shareholders Immatics Major Shareholders Tyra Biosciences Major Shareholders Valneva Major Shareholders Maravai LifeSciences Major Shareholders Relay Therapeutics Major Shareholders GH Research Major Shareholders Stoke Therapeutics Major Shareholders Kura Oncology Major Shareholders This page (NASDAQ:SLS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.